CUSIP: 396879108
What is CUSIP 396879108?
CUSIP 396879108 identifies GLSI - Greenwich LifeSciences, Inc. - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 396879108:
As of 31 Dec 2025, 49 institutional investors reported holding 1,327,035 shares of Greenwich LifeSciences, Inc. - COM (GLSI).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,327,035 | $27,880,174 | +$3,310,098 | $21.01 | 49 |
| 2025 Q3 | 1,214,197 | $12,081,502 | -$993,187 | $9.95 | 51 |
| 2025 Q2 | 1,231,674 | $11,172,252 | +$1,418,411 | $9.07 | 51 |
| 2025 Q1 | 1,161,900 | $11,085,101 | -$205,962 | $9.54 | 45 |
| 2024 Q4 | 1,180,752 | $13,259,332 | +$407,207 | $11.23 | 41 |
| 2024 Q3 | 1,140,359 | $16,387,790 | +$1,070,451 | $14.37 | 37 |
| 2024 Q2 | 1,020,904 | $17,621,924 | +$5,916,352 | $17.26 | 33 |
| 2024 Q1 | 644,693 | $12,855,318 | +$2,858,855 | $19.94 | 28 |
| 2023 Q4 | 535,932 | $5,638,113 | +$78,914 | $10.52 | 26 |
| 2023 Q3 | 537,344 | $4,749,933 | -$815,596 | $8.84 | 23 |
| 2023 Q2 | 628,750 | $6,063,402 | -$2,464,652 | $9.64 | 23 |
| 2023 Q1 | 827,405 | $11,410,584 | +$2,146,251 | $13.79 | 26 |
| 2022 Q4 | 671,331 | $10,202,395 | -$1,650,874 | $15.20 | 20 |
| 2022 Q3 | 792,698 | $7,214,000 | -$2,079,093 | $9.10 | 17 |
| 2022 Q2 | 1,031,908 | $8,742,000 | -$137,415 | $8.47 | 25 |
| 2022 Q1 | 931,134 | $18,285,000 | +$2,168,100 | $19.61 | 33 |
| 2021 Q4 | 795,934 | $19,393,000 | -$3,602,924 | $24.33 | 35 |
| 2021 Q3 | 815,668 | $31,919,000 | +$224,021 | $39.07 | 36 |
| 2021 Q2 | 810,815 | $36,440,000 | +$25,369,213 | $44.94 | 30 |
| 2021 Q1 | 259,749 | $8,895,818 | +$5,029,510 | $34.09 | 19 |
| 2020 Q4 | 111,845 | $4,075,294 | +$4,065,221 | $36.46 | 15 |
| 2020 Q3 | 277 | $1,000 | +$1,000 | $3.61 | 1 |